Aminopeptidase N inhibitors and SARS [1]

Lancet

Volumn 361, Issue 9368, 2003, Pages 1558-

  Kontoyiannis, Dimitrios P ^a   Pasqualini, Renata ^a   Arap, Wadih ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BESTATIN; MICROSOMAL AMINOPEPTIDASE; MONOCLONAL ANTIBODY;

CORONAVIRUS; DRUG EFFECT; DRUG USE; EPIDEMIC; HIGH RISK POPULATION; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; LETTER; LUNG INJURY; PNEUMONIA; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN EXPRESSION; SEVERE ACUTE RESPIRATORY SYNDROME; SOUTHEAST ASIA; TRAVEL; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS STRAIN;

EID: 0038185271     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)13186-8     Document Type: Letter

References (5)

1. Ksiazek TG, Erdman D, Goldsmith C, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. Published online April 10, 2003.
2. McIntosh K. Coronaviruses. Mandell G.L., Bennett J.E., Dolin R. Mandell, Douglas and Bennett's Principle and Practice of Infectious Diseases. 5th edn:2000;Churchill Livingston, Philadelphia.
3. Yeager C.L., Ashmun R.A., Williams R.K., et al. Human aminopeptidase N is a receptor for human coronavirus 229E. Nature. 357:1992;420-422.
4. Delmas B., Gelfi J., L'Haridon R., et al. Aminopeptidase N is a major receptor for the entero-pathogenic coronavirus TGEV. Nature. 357:1992;417-420.
5. Pasqualini R., Koivunen E., Kain R., et al. CD13 is an angiogenesis regulator and functions a receptor for peptides that target tumor vasculature. Cancer Res. 60:2000;722-727.